Skip to main content
Premium Trial:

Request an Annual Quote

NeoGenomics Launches $32.2M Stock Offering

NEW YORK (GenomeWeb) – NeoGenomics today said that it has priced an offering of 7 million shares of common stock at $4.60 per share.

The Ft. Myers, Fla.-based genetic testing services firm expects to raise gross proceeds of $32.2 million from the offering, which is expected to close on Aug. 20. Net proceeds are anticipated at around $30 million.

NeoGenomics said it will use the proceeds from the offering for working capital and general corporate purposes, which could include potential acquisitions and repayment of debt.

William Blair is the sole book-running manager on the offering, and Craig-Hallum Capital Group is co-lead manager. Stephens, Roth Capital Partners, Sidoti & Co., and Dawson James Securities are serving as co-managers on the offering.

The underwriters have a 30-day option to purchase up to an additional 1.05 million shares of common stock to cover any over-allotments.

NeoGenomics recently reported a 33 percent increase in second quarter revenues year over year and turned a profit in the quarter of $274,000, or $.01 per share. As of June 30 it held $5.0 million in cash and cash equivalents.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.